A Time to Settle; A Time to Fight
This article was originally published in RPM Report
Executive Summary
It seems like an odd time to fight with the government fraud investigators over false claims suits. The public perception of white-collar greed is back in vogue; more money is headed to the fraud investigators at HHS and the Justice Department, top government leaders are putting their public reputations at stake on big cash recoveries, and pharma settlement figures are steadily around $500 million or more.But J&J and Allergan look ready to fight back.